TNNI3 and ischemia: Animal studies have demonstrated that platelet-rich plasma can reduce cTnI expression in myocardial cells following ischemia-reperfusion injury by promoting AMP-activated protein kinase phosphorylation and modulating macrophage activity, thereby exerting cardioprotective effects [17].